Thomas C. Luke
Public Health and Preventive Medicine
503 Robert Grant Ave
Silver Spring, MD 20910
Silver Spring, MD 20910
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
A single dose of purified human antibody from transchromosomic bovines mitigates aerosolized Venezuelan equine encephalitis virus disease in cynomolgus macaques.
Journal: PloS one
Published: December 11, 2025
Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial.
Journal: The Journal of infectious diseases
Published: March 19, 2024
No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret model.
Journal: PloS one
Published: August 17, 2023
Transchromosomic bovine-derived anti-SARS-CoV-2 polyclonal human antibodies protects hACE2 transgenic hamsters against multiple variants.
Journal: iScience
Published: April 18, 2023
Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague.
Journal: Antibodies (Basel, Switzerland)
Published: March 10, 2023
A fully human monoclonal antibody possesses antibody-dependent cellular cytotoxicity (ADCC) activity against the H1 subtype of influenza A virus by targeting a conserved epitope at the HA1 protomer interface.
Journal: Journal of medical virology
Published: February 24, 2023
Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19.
Journal: The Journal of infectious diseases
Published: September 14, 2022
Increased Antibody Avidity and Cross-Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Variants by Hyperimmunized Transchromosomic Bovine-Derived Human Immunoglobulins for Treatment of Coronavirus Disease 2019.
Journal: The Journal of infectious diseases
Published: November 10, 2021
Protection of human ACE2 transgenic Syrian hamsters from SARS CoV-2 variants by human polyclonal IgG from hyper-immunized transchromosomic bovines.
Journal: bioRxiv : the preprint server for biology
Published: August 03, 2021
Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants.
Journal: Human vaccines & immunotherapeutics
Published: July 06, 2021
Skin Swabbing for Staphylococcus aureus-Targeting Phages.
Journal: Military medicine
Published: January 22, 2021
Last Updated: 09/26/2026